FDA NDC Directory · JSON-LD · Markdown

Paclitaxel

NDC 0703-3213 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerTeva Parenteral Medicines, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA075184
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsPACLITAXEL (6 mg/mL)
Marketing started20200707
Package count1

External sources

Source: openFDA. Public-domain (CC0).